News

Supernus Pharmaceuticals Showcases Commitment at Neuropsychiatry Summit

Supernus Pharmaceuticals Showcases Commitment at Neuropsychiatry Summit

Supernus Pharmaceuticals Joins Neuropsychiatry Summit

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is leading the way in biopharmaceutical innovation geared towards treating diseases of the central nervous system (CNS). With a strong focus on improving patient care, the company is thrilled to announce its participation in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit. On this important day, Jack Khattar, Supernus' President and CEO, will join the event virtually, engaging in meaningful discussions about the future of CNS therapies.

Details on the Upcoming Fireside Chat

This virtual fireside chat is set for Thursday, September 26, 2024, at 8:40 a.m. ET. Khattar's presence at the summit highlights Supernus' commitment to addressing neuropsychiatric disorders. Attendees can look forward to gaining valuable insights into the company’s strategies and future plans for developing innovative therapies aimed at CNS conditions.

How to Access the Live Webcast

If you're interested in following the discussions, you'll be able to watch a live webcast. You can easily access it through Supernus Pharmaceuticals' official website, making sure that stakeholders can stay up-to-date on the latest developments in neuropsychiatry and Supernus' contributions to this vital field.

Supernus' Product Portfolio and Commitment to CNS Care

Supernus Pharmaceuticals features a diverse product portfolio targeting key areas within the CNS landscape. Their current offerings include effective treatments for conditions such as epilepsy, migraines, ADHD, and more. Moreover, the company is actively working to address complex challenges like hypomobility related to Parkinson's disease and other CNS disorders, showcasing their relentless drive for medical innovation.

Focus on Research and Development

The company is in the process of developing new therapies that hold significant promise for improving patients' lives. As they expand their offerings, Supernus is committed to delivering safe and effective treatments aligned with patients' ever-changing needs. With robust clinical trials and extensive research, the organization is determined to find and introduce groundbreaking solutions for neurological health.

Core Philosophy and Vision

Supernus Pharmaceuticals operates with a core philosophy centered on enhancing patient outcomes. The leadership team believes that investing in innovative research and focusing on patient care can make a meaningful difference in the healthcare community. Their dedication to improving the quality of life for those battling CNS-related conditions drives their ongoing work and collaboration throughout the industry.

Looking Ahead: The Future of Supernus Pharmaceuticals

The outlook for Supernus is bright as the company continues to explore new avenues in CNS treatment. With various projects underway, stakeholders can expect a range of promising developments that will enhance their already impressive product lineup. As they progress, Supernus remains dedicated to meeting unmet medical needs and ensuring that innovative treatment options are readily available to those in need.

Contact Information

If you have any further questions, please reach out to the Supernus Pharmaceuticals team:

Jack A. Khattar, President and CEO
Timothy C. Dec, Senior Vice President and CFO
Phone: (301) 838-2591

You can also contact Peter Vozzo
ICR Westwicke
Phone: (443) 213-0505
Email: peter.vozzo@westwicke.com

Frequently Asked Questions

What is Supernus Pharmaceuticals' main focus?

Supernus Pharmaceuticals is committed to developing and commercializing products for the treatment of CNS diseases.

When will the summit take place?

The TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit is scheduled for September 26, 2024.

Who will represent Supernus at the summit?

Jack Khattar, the President and CEO, will represent Supernus Pharmaceuticals in a fireside chat.

How can I watch the live presentation?

The live webcast can be accessed through the Supernus Pharmaceuticals website on the day of the event.

What types of treatments does Supernus Pharmaceuticals offer?

Supernus offers treatments for epilepsy, migraines, ADHD, and several other CNS conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 8

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 7

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 6

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading

Top 5 Most Recently Viewed Articles

Brady Board Member's Strategic Stock Purchase Signals Growth

Updated Category News Views 104

Understanding the Recent Insider Transaction at Brady Patrick Allender, a Board Member at Brady Corporation (NYSE: BRC), recently made headlines by purchasing 1,809 shares in a transaction valued at $135,005, as disclosed in a Form 4 filing. This event has garnered attention as insiders often provide signals about their belief in a company's potential growth and value....

Continue Reading
Faruqi & Faruqi Investigates Potential Claims for WM Technology

Updated Category News Views 75

Faruqi & Faruqi Investigates Potential Claims for WM Technology Faruqi & Faruqi, LLP, a prominent national law firm specializing in securities litigation, is reaching out to investors affected by WM Technology, Inc. (NASDAQ: MAPS). The firm encourages investors who have experienced losses exceeding $75,000 to discuss their legal options directly with James (Josh) Wilson,...

Continue Reading
Innovative Startups Showcase Promise for Long-Term Healthcare

Updated Category News Views 155

Innovative Startups Showcase Promise for Long-Term Healthcare In a remarkable event that emphasizes tangible advancements in the long-term care sector, eCap has selected 18 early-stage startups to present their cutting-edge solutions at the eCapWest2025 event in Phoenix. Facilitated by the dynamic Randi Zuckerberg, this startup showcase is designed to highlight...

Continue Reading
Forecasting the Surge in Global Computer Vision Growth

Updated Category News Views 95

Understanding the Computer Vision Revolution Computer vision is a fascinating area of artificial intelligence (AI) that enables machines to interpret visual data drawn from images and videos. This technology aims to replicate the human ability to process visual information effectively, making it invaluable in various fields today. The algorithms driving computer vision...

Continue Reading
Northern Data AG Investigation Highlights Shareholder Rights

Updated Category News Views 241

Overview of Northern Data AG Investigation As investors look to ensure fair treatment in corporate actions, the potential acquisition of Northern Data AG has raised significant questions. The proposed transaction suggests that shareholders of Northern Data will receive 2.0281 shares of Rumble Inc. common stock for each share they hold. This arrangement prompts a closer...

Continue Reading